Biogen (NASDAQ:BIIB – Free Report) had its price target decreased by BMO Capital Markets from $156.00 to $139.00 in a report ...
Tamarack Valley Energy (TSE:TVE – Free Report) had its target price hoisted by BMO Capital Markets from C$6.00 to C$6.50 in a report published on Thursday morning,BayStreet.CA reports. TVE has been ...
BMO Capital analyst Evan Seigerman lowered the firm’s price target on Biogen (BIIB) to $139 from $156 and keeps a Market Perform rating on the ...
BMO Capital raised the firm’s price target on HubSpot (HUBS) to $885 from $690 and keeps an Outperform rating on the shares. The company ...
BMO Capital Markets. "As the industry evolves, our priority is providing exceptional service to our clients while delivering more integrated and innovative solutions to grow our market leading ...
Fintel reports that on February 11, 2025, BMO Capital downgraded their outlook for Q32 Bio (NasdaqGM:QTTB) from Outperform to Market Perform. Analyst Price Forecast Suggests 458.11% Upside As of ...
We recently compiled a list of the 10 Best GARP Stocks That Pay Dividends. In this article, we are going to take a look at ...
BMO Capital lowered the firm’s price target on OneStream (OS) to $34 from $38 and keeps an Outperform rating on the shares. The company’s Q4 results showed moderate upside on revenue and more ...
We recently compiled a list of the 10 Best GARP Stocks That Pay Dividends. In this article, we are going to take a look at ...
Signs of resurgent inflation shown in January's consumer-price index can't be "easily explained away" by seasonal factors, and pressure will build on the Federal Reserve to stay on hold for a ...
On Tuesday, BMO Capital Markets reaffirmed their Outperform rating on Beam Therapeutics Inc (NASDAQ:BEAM), with a steady price target of $57.00. Currently trading at $26.57, the stock appears ...